ed-effects model showed no significant treatment effect (IV vs UC) over 12 months (P=.06). However, participants with higher baseline HbA

and those in the first time period experienced greater improvements in HbA

. Both groups reported similar improvements in treatment satisfaction throughout the study.

Patients enrolled in the…[Read more]